Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) flaunted slowness of -9.00% at $1.82, as the Stock market unbolted on February 12, 2021. During the day, the stock rose to $1.99 and sunk to $1.70 before settling in for the price of $2.00 at the close. Taking a more long-term approach, TNXP posted a 52-week range of $0.39-$2.46.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 92.80%. This publicly-traded company’s shares outstanding now amounts to $323.91 million, simultaneously with a float of $156.47 million. The organization now has a market capitalization sitting at $647.79 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8990, while the 200-day Moving Average is $0.8105.
Tonix Pharmaceuticals Holding Corp. (TNXP) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Tonix Pharmaceuticals Holding Corp. industry. Tonix Pharmaceuticals Holding Corp.’s current insider ownership accounts for 0.10%, in contrast to 2.70% institutional ownership. According to the most recent insider trade that took place on Dec 30, this organization’s Chief Executive Officer bought 35,000 shares at the rate of 0.68, making the entire transaction reach 23,800 in total value, affecting insider ownership by 118,267. Preceding that transaction, on Aug 31, Company’s Director bought 5,500 for 0.89, making the whole transaction’s value amount to 4,895. This particular insider is now the holder of 10,000 in total.
Tonix Pharmaceuticals Holding Corp. (TNXP) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.09 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.11) by $0.02. This company achieved a return on equity of -173.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
Tonix Pharmaceuticals Holding Corp.’s EPS increase for this current 12-month fiscal period is 92.80% and is forecasted to reach -0.24 in the upcoming year.
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Trading Performance Indicators
Let’s observe the current performance indicators for Tonix Pharmaceuticals Holding Corp. (TNXP). It’s Quick Ratio in the last reported quarter now stands at 14.20. The Stock has managed to achieve an average true range (ATR) of 0.21.
In the same vein, TNXP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.50, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.24 at the market close of one year from today.
Technical Analysis of Tonix Pharmaceuticals Holding Corp. (TNXP)
Now, what If we examine the latest scores posted by [Tonix Pharmaceuticals Holding Corp., TNXP]. During the last 5-days, its volume was better the volume of 60.51 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 81.92% While, its Average True Range was 0.2385.
Raw Stochastic average of Tonix Pharmaceuticals Holding Corp. (TNXP) in the period of the previous 100 days is set at 81.37%, which indicates a major rise in contrast to 75.71% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 137.43% that was higher than 90.46% volatility it exhibited in the past 100-days period.